Fukada, M.; Matsuhashi, N.; Takahashi, T.; Sugito, N.; Heishima, K.; Akao, Y.; Yoshida, K.
Tumor Tissue MIR92a and Plasma MIRs21 and 29a as Predictive Biomarkers Associated with Clinicopathological Features and Surgical Resection in a Prospective Study on Colorectal Cancer Patients. J. Clin. Med. 2020, 9, 2509.
https://doi.org/10.3390/jcm9082509
AMA Style
Fukada M, Matsuhashi N, Takahashi T, Sugito N, Heishima K, Akao Y, Yoshida K.
Tumor Tissue MIR92a and Plasma MIRs21 and 29a as Predictive Biomarkers Associated with Clinicopathological Features and Surgical Resection in a Prospective Study on Colorectal Cancer Patients. Journal of Clinical Medicine. 2020; 9(8):2509.
https://doi.org/10.3390/jcm9082509
Chicago/Turabian Style
Fukada, Masahiro, Nobuhisa Matsuhashi, Takao Takahashi, Nobuhiko Sugito, Kazuki Heishima, Yukihiro Akao, and Kazuhiro Yoshida.
2020. "Tumor Tissue MIR92a and Plasma MIRs21 and 29a as Predictive Biomarkers Associated with Clinicopathological Features and Surgical Resection in a Prospective Study on Colorectal Cancer Patients" Journal of Clinical Medicine 9, no. 8: 2509.
https://doi.org/10.3390/jcm9082509
APA Style
Fukada, M., Matsuhashi, N., Takahashi, T., Sugito, N., Heishima, K., Akao, Y., & Yoshida, K.
(2020). Tumor Tissue MIR92a and Plasma MIRs21 and 29a as Predictive Biomarkers Associated with Clinicopathological Features and Surgical Resection in a Prospective Study on Colorectal Cancer Patients. Journal of Clinical Medicine, 9(8), 2509.
https://doi.org/10.3390/jcm9082509
